STAAR Surgical Company (STAA)
Solvency ratios
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.27 | 1.25 | 1.32 | 1.31 | 1.30 |
STAAR Surgical Company has consistently maintained a debt-free capital structure with debt-to-assets, debt-to-capital, and debt-to-equity ratios all at 0.00 for the past five years. This indicates that the company has financed its operations primarily through equity rather than debt. Additionally, the financial leverage ratio has ranged from 1.25 to 1.32 over the same period, suggesting that the company has utilized a moderate level of financial leverage to support its operations and growth. Overall, STAAR Surgical Company appears to have a strong solvency position with a low reliance on debt for its financing needs.
Coverage ratios
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Interest coverage | 2,341.42 | 2,576.59 | 5,556.50 | 225.63 | 164.61 |
The interest coverage ratio measures a company's ability to meet its interest expenses with its operating income. STAAR Surgical Company's interest coverage has shown significant fluctuations over the past five years, ranging from a low of 164.61 in 2019 to a high of 5,556.50 in 2021.
The trend indicates that STAAR Surgical Company has generally been able to cover its interest expenses comfortably in recent years, with particularly strong performance in 2021. This suggests that the company's operating income has been robust relative to its interest obligations during these periods.
However, the significant fluctuations in the interest coverage ratio raise some questions about the company's financial stability and the consistency of its earnings. Investors and creditors may want to further investigate the reasons behind these fluctuations to assess the company's long-term financial health and risk profile.